A $226B Copper Spending Jackpot
On November 15, 2021, President Biden signed the biggest infrastructure spending bill of all time. A staggering $226 BILLION is earmarked for projects requiring huge amounts of copper. Turns out, copper is a desperately needed mineral to power the green revolution of clean, renewable energy.
See Who Can Benefit From this Initiative

FSTX Insider Trading (F-star Therapeutics)

Insider Ownership Percentage: 2.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $9,785.06

F-star Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at F-star Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

F-star Therapeutics Share Price & Price History

Current Price: $2.33
Price Change: Price Decrease of -0.01 (-0.43%)
As of 05/17/2022 02:01 PM ET

This chart shows the closing price history over time for FSTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Options Expert is Giving Everything Away!
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you!

His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
Get your copy today!

F-star Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/2/2021Louis KayitalireInsiderSell64$6.83$437.12View SEC Filing Icon  
10/4/2021Louis KayitalireInsiderSell64$7.23$462.72View SEC Filing Icon  
7/2/2021Louis KayitalireInsiderSell1,054$8.43$8,885.22View SEC Filing Icon  
See Full Table
High Arch Potential Stock
If you're looking for a hot new sector, watch this stock closely.
Click for ticker & full details

SEC Filings (Institutional Ownership Changes) for F-star Therapeutics (NASDAQ:FSTX)

51.67% of F-star Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FSTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

F-star Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022Goldman Sachs Group Inc.33,802$0.12M0.0%N/A0.157%Search for SEC Filing on Google Icon
5/16/2022State Street Corp53,150$0.19M0.0%+15.6%0.247%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC249,140$0.88M0.0%-13.9%1.156%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.598,437$2.12M0.0%-20.0%2.776%Search for SEC Filing on Google Icon
5/12/2022Anson Funds Management LP185,261$0.66M0.1%-40.2%0.859%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.295,947$1.05M0.0%+1.6%1.373%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.21,335$76K0.0%+152.7%0.099%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.601,394$2.13M0.0%+145.4%2.789%Search for SEC Filing on Google Icon
5/4/2022Envestnet Asset Management Inc.13,564$48K0.0%N/A0.063%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC45,320$0.23M0.0%+191.5%0.220%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC5,862$29K0.0%N/A0.028%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC289,411$1.45M0.0%+142.4%1.403%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.8,444$42K0.0%N/A0.041%Search for SEC Filing on Google Icon
1/21/2022Russell Investments Group Ltd.245,077$1.23M0.0%+38.2%1.188%Search for SEC Filing on Google Icon
11/16/2021Janus Henderson Group PLC678,391$4.94M0.0%-5.0%3.289%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC15,547$0.11M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.981,249$7.18M0.0%-8.7%4.759%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP49,933$0.37M0.0%-50.1%0.242%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC119,411$0.87M0.0%-18.8%0.579%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC145,431$1.06M0.0%+11.6%0.705%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC170,000$1.24M0.2%-57.5%0.824%Search for SEC Filing on Google Icon
11/8/2021Russell Investments Group Ltd.177,286$1.30M0.0%+1.4%0.860%Search for SEC Filing on Google Icon
11/5/2021Truist Financial Corp79,092$0.58M0.0%+71.6%0.384%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley7,868$68K0.0%+65.0%0.038%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD827,728$7.11M0.0%N/A4.274%Search for SEC Filing on Google Icon
8/17/2021Boxer Capital LLC1,751,428$15.05M0.5%N/A9.044%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC442,780$3.80M0.0%+1,159.4%2.286%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.1,075,000$9.23M0.0%+1,333.3%5.551%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.150,000$1.29M0.0%N/A0.775%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley7,868$68K0.0%+65.0%0.041%Search for SEC Filing on Google Icon
8/16/2021Maven Securities LTD144,932$1.26M0.1%N/A0.748%Search for SEC Filing on Google Icon
8/16/2021State Street Corp25,070$0.22M0.0%N/A0.129%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC147,011$1.26M0.0%+6.3%0.759%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp34,452$0.30M0.0%+86.8%0.178%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC130,279$1.12M0.0%+136.9%0.673%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.773,215$6.64M0.0%+46.3%3.993%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP39,184$0.34M0.0%N/A0.202%Search for SEC Filing on Google Icon
8/12/2021Monashee Investment Management LLC400,000$3.44M0.4%N/A2.065%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp45,062$0.39M0.0%N/A0.233%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.288,750$2.48M0.0%+548.5%1.491%Search for SEC Filing on Google Icon
8/4/2021Russell Investments Group Ltd.174,773$1.50M0.0%N/A0.902%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.75,000$0.81M0.0%N/A0.824%Search for SEC Filing on Google Icon
5/18/2021Verition Fund Management LLC128,994$1.40M0.0%N/A1.418%Search for SEC Filing on Google Icon
5/17/2021EcoR1 Capital LLC46,000$0.50M0.0%N/A0.505%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC138,311$1.50M0.0%-23.9%1.520%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp18,444$0.20M0.0%+76.5%0.203%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC55,000$0.60M0.0%+184.5%0.604%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC2,451$27K0.0%-38.7%0.027%Search for SEC Filing on Google Icon
4/23/2021BRYN MAWR TRUST Co10,000$0.11M0.0%N/A0.110%Search for SEC Filing on Google Icon
2/16/2021Endurant Capital Management LP20,445$0.20M0.1%N/A0.474%Search for SEC Filing on Google Icon
2/11/2021Arcadia Investment Management Corp MI3,000$30K0.0%N/A0.069%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC181,789$1.79M0.0%N/A4.211%Search for SEC Filing on Google Icon
2/10/2021Connolly Sarah T.53,001$0.52M0.5%N/A1.228%Search for SEC Filing on Google Icon
2/8/2021Parsons Capital Management Inc. RI23,129$0.23M0.0%N/A0.536%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.44,820$0.44M0.0%N/A1.038%Search for SEC Filing on Google Icon
2/1/2021Atlas Venture Advisors Inc.574,996$5.68M1.3%N/A13.319%Search for SEC Filing on Google Icon
1/15/2021Private Capital Advisors Inc.13,083$0.13M0.0%N/A0.303%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
F-star Therapeutics logo
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.
Read More on F-star Therapeutics

Today's Range

Now: $2.33
Low: $2.33
High: $2.40

50 Day Range

MA: $3.18
Low: $2.18
High: $4.02

52 Week Range

Now: $2.33
Low: $2.07
High: $9.71

Volume

4,817 shs

Average Volume

149,571 shs

Market Capitalization

$50.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Who are the company insiders with the largest holdings of F-star Therapeutics?

F-star Therapeutics' top insider shareholders include:
  1. Louis Kayitalire (Insider)
Learn More about top insider investors at F-star Therapeutics.

Who are the major institutional investors of F-star Therapeutics?

F-star Therapeutics' top institutional shareholders include:
  1. Russell Investments Group Ltd. — 2.79%
  2. Vanguard Group Inc. — 2.78%
  3. BlackRock Inc. — 1.37%
  4. Renaissance Technologies LLC — 1.16%
  5. Anson Funds Management LP — 0.86%
  6. State Street Corp — 0.25%
Learn More about top institutional investors of F-star Therapeutics stock.

Which institutional investors are selling F-star Therapeutics stock?

Within the last quarter, FSTX stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. Anson Funds Management LP
  3. Renaissance Technologies LLC
  4. Simplex Trading LLC

Which institutional investors are buying F-star Therapeutics stock?

In the last quarter, FSTX stock was acquired by institutional investors including:
  1. Russell Investments Group Ltd.
  2. Goldman Sachs Group Inc.
  3. Envestnet Asset Management Inc.
  4. JPMorgan Chase & Co.
  5. State Street Corp
  6. BlackRock Inc.
Is the US Military Secretly Under Chinese Control?
Alarmingly, the answer may be "yes". Communist China now controls 80% of the lithium that powers most US military vehicles and equipment. The threat level is so high that the White House recently declared a state of emergency on lithium...
Discover How To Invest in Lithium Mining